Related Experiment Video
Updated: Jul 3, 2026
05:18
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Pediatric experience with the VentrAssist LVAD.
Peter N Ruygrok1, Don S Esmore, Peter M Alison
1New Zealand Heart and Lung Transplant Service, Auckland City Hospital, Auckland, New Zealand. pruygrok@adhb.govt.nz
The Annals of Thoracic Surgery
|July 22, 2008
Summary
This study reports the first use of the VentrAssist left ventricular assist device in pediatric patients with severe heart failure. The device showed promise, enabling survival beyond one year for all three children.
Area of Science:
- Pediatric Cardiology
- Medical Device Technology
- Cardiovascular Surgery
Background:
- End-stage heart failure in children presents significant management challenges.
- Novel therapeutic strategies are crucial for improving outcomes in pediatric heart failure patients.
Observation:
- Three pediatric patients (
- Despite critical illness at presentation, all patients were discharged and survived over one year post-implantation.
Findings:
- The VentrAssist facilitated positive outcomes, including successful transplantation in one patient and recovery in another.
- Complications observed, such as infection and thromboembolism, were consistent with those seen in adult LVAD recipients.
Implications:
- The VentrAssist represents a potential significant advancement in treating pediatric patients with advanced heart failure.
- Further research and clinical trials are warranted to establish the long-term efficacy and safety of this device in pediatric populations.
